Paper41267972
Biology of PEST-containing nuclear proteins as potential targets in ovarian cancer (Review).
Liu H and 10 others. Oncol Lett, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Biology of PEST-containing nuclear proteins as potential targets in ovarian cancer (Review). Papers, record 41267972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41267972
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biology of PEST-containing nuclear proteins as potential targets in ovarian cancer (Review).
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References176
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26596838 | Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53. | Tumour Biol | 2016 | https://conductscience.org/library/papers/26596838 | PubMed |
| 2 | 35784636 | Carrier-free nanoprodrug for p53-mutated tumor therapy via concurrent delivery of zinc-manganese dual ions and ROS. | Bioact Mater | 2023 | https://conductscience.org/library/papers/35784636 | PubMed |
| 3 | 30640704 | Ovarian cancer: screening and future directions. | Int J Gynecol Cancer | 2019 | https://conductscience.org/library/papers/30640704 | PubMed |
| 4 | 15576594 | Beyond the ivory tower. The scientific consensus on climate change. | Science | 2004 | https://conductscience.org/library/papers/15576594 | PubMed |
| 5 | 21999765 | Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression. | Cancer Sci | 2012 | https://conductscience.org/library/papers/21999765 | PubMed |
| 6 | 30892093 | Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells. | Artif Cells Nanomed Biotechnol | 2019 | https://conductscience.org/library/papers/30892093 | PubMed |
| 7 | 16174239 | Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer. | Int J Gynecol Cancer | 2005 | https://conductscience.org/library/papers/16174239 | PubMed |
| 8 | 20940128 | p53 at a glance. | J Cell Sci | 2010 | https://conductscience.org/library/papers/20940128 | PubMed |
| 9 | 29527331 | Targeting oncogenic Myc as a strategy for cancer treatment. | Signal Transduct Target Ther | 2018 | https://conductscience.org/library/papers/29527331 | PubMed |
| 10 | 10468583 | The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10468583 | PubMed |
| 11 | 21496237 | Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. | J Exp Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21496237 | PubMed |
| 12 | 17081971 | Wnt/beta-catenin signaling in development and disease. | Cell | 2006 | https://conductscience.org/library/papers/17081971 | PubMed |
| 13 | 25285018 | Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins. | Onco Targets Ther | 2014 | https://conductscience.org/library/papers/25285018 | PubMed |
| 14 | 27308631 | MDM2/MDMX: Master negative regulators for p53 and RB. | Mol Cell Oncol | 2016 | https://conductscience.org/library/papers/27308631 | PubMed |
| 15 | 21430439 | βTrCP regulates BMI1 protein turnover via ubiquitination and degradation. | Cell Cycle | 2011 | https://conductscience.org/library/papers/21430439 | PubMed |
| 16 | 21270607 | Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancer. | Int J Gynecol Cancer | 2011 | https://conductscience.org/library/papers/21270607 | PubMed |
| 17 | 32741700 | Targeting p53 for the treatment of cancer. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/32741700 | PubMed |
| 18 | 21779514 | Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. | Genes Cancer | 2011 | https://conductscience.org/library/papers/21779514 | PubMed |
| 19 | 31477831 | UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway. | Oncogene | 2020 | https://conductscience.org/library/papers/31477831 | PubMed |
| 20 | 10521480 | The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10521480 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41267972
GET https://conductscience.org/api/papers/v1/41267972/references?page=2